Assignee profile:

VIVUS, Inc.

City:

Mountain View, California

Country:

United States

Published Applications:

25

Last publication date:

2015-01-08

Patent Grants:

16

Last grant date:

2015-04-21

Top Inventors for applications by VIVUS, Inc.

These are the the leading inventors for applications assigned to VIVUS, Inc.:

Recent patent applications by VIVUS, Inc.

VIVUS, Inc. based in Mountain View, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2015-01-08 ✅ Patent 9,011,906 granted on 2015-04-21
US20150010626A1
Human necessities

Escalating dosing regimen for effecting weight loss and treating obesity

#2 | 2015-01-08 ✅ Patent 9,011,905 granted on 2015-04-21
US20150010625A1
Human necessities

Low dose topiramate/phentermine composition and methods of use thereof

#3 | 2014-07-03 ✅ Patent 8,895,057 granted on 2014-11-25
US20140187623A1
Human necessities

Escalating dosing regimen for effecting weight loss and treating obesity

#4 | 2014-04-03
US20140094511A1
Human necessities

Treatment of Obstructive Sleep Apnea Syndrome with a Combination of a Carbonic Anhydrase Inhibitor and an Additional Active Agent

#5 | 2014-03-27
US20140088162A1
Human necessities

Treatment of Pulmonary Hypertension with Carbonic Anhydrase Inhibitors

#6 | 2014-02-06 ✅ Patent 8,895,058 granted on 2014-11-25
US20140037723A1
Human necessities

Low dose topiramate/phentermine composition and methods of use thereof

#7 | 2013-11-07
US20130296324A1
Human necessities

NOVEL COMPOSITIONS COMPRISING A PHOSPHODIESTERASE-5 INHIBITOR AND THEIR USE IN METHODS OF TREATMENT

#8 | 2012-08-02 ✅ Patent 8,536,138 granted on 2013-09-17
US20120196881A1
Human necessities

Treatment of pulmonary hypertension with carbonic anhydrase inhibitors

#9 | 2011-10-27
US20110262535A1
Human necessities

Low Dose Topiramate / Phentermine Composition and Methods of Use Thereof

#10 | 2011-09-15
US20110224196A1
Human necessities

TREATMENT OF OBSTRUCTIVE SLEEP APNEA SYNDROME WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ADDITIONAL ACTIVE AGENT

#11 | 2011-02-10 ✅ Patent 8,440,671 granted on 2013-05-14
US20110034471A1
Human necessities

Compositions comprising a phoshodiesterase-5 inhibitor and their use in methods of treatment

#12 | 2010-08-26 ✅ Patent 8,580,298 granted on 2013-11-12
US20100215739A1
Human necessities

Low dose topiramate/phentermine composition and methods of use thereof

#13 | 2010-04-29 ✅ Patent 8,802,636 granted on 2014-08-12
US20100105765A1
Human necessities

Combination therapy for treatment of sleep apnea

#14 | 2010-04-08
US20100087402A1
Human necessities

Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders

#15 | 2009-12-10 ✅ Patent 8,580,299 granted on 2013-11-12
US20090304785A1
Human necessities

Escalating dosing regimen for effecting weight loss and treating obesity

#16 | 2008-12-18 ✅ Patent 8,071,557 granted on 2011-12-06
US20080312163A1
Human necessities

Treatment of pulmonary hypertension with carbonic anhydrase inhibitors

#17 | 2008-09-18
US20080227749A1
Human necessities

CARRAGEENAN-BASED FORMULATIONS AND ASSOCIATED METHODS OF USE

#18 | 2006-10-19 ✅ Patent 7,674,776 granted on 2010-03-09
US20060234952A1
Human necessities

Combination therapy for effecting weight loss and treating obesity

#19 | 2006-10-19 ✅ Patent 7,659,256 granted on 2010-02-09
US20060234951A1
Human necessities

Combination therapy for effecting weight loss and treating obesity

#20 | 2006-10-19 ✅ Patent 7,553,818 granted on 2009-06-30
US20060234950A1
Human necessities

Combination therapy for effecting weight loss and treating obesity

#21 | 2006-06-06 ✅ Patent 7,056,890 granted on 2006-06-06
US10454368
-

Combination therapy for effecting weight loss and treating obesity

#22 | 2006-02-23 ✅ Patent 7,226,910 granted on 2007-06-05
US20060041021A1
Human necessities

Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists

#23 | 2005-10-27
US20050239742A1
Human necessities

Carrageenan-based formulations and associated methods of use

#24 | 2005-09-20 ✅ Patent 6,946,141 granted on 2005-09-20
US9996407
-

As-needed administration of tricyclic and other non-SRI antidepressant drugs to treat premature ejaculation

#25 | 2005-03-31
US20050070516A1
Human necessities

As-needed administration of an androgenic agent to enhance female desire and responsiveness

Also check out Vivus, Inc.'s (Mountain View, United States) applicant profile with 5 patent applications submitted.

AssigneeID:

44749 ⎘